2020 年 4 月至 7 月，印度新冠肺炎重症患者中出现耐多药念珠菌血症感染。
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.
出版信息
Emerg Infect Dis. 2020 Nov;26(11):2694-2696. doi: 10.3201/eid2611.203504. Epub 2020 Aug 27.
Abstract
In New Delhi, India, candidemia affected 15 critically ill coronavirus disease patients admitted to an intensive care unit during April-July 2020. Candida auris accounted for two thirds of cases; case-fatality rate was high (60%). Hospital-acquired C. auris infections in coronavirus disease patients may lead to adverse outcomes and additional strain on healthcare resources.
摘要
在印度新德里，2020 年 4 月至 7 月期间，有 15 名重症新冠肺炎患者入住重症监护病房，并发念珠菌血症。其中，有三分之二的病例是由耳念珠菌引起的；病死率很高（60%）。新冠肺炎患者发生医院获得性耳念珠菌感染可能导致不良后果，并给医疗资源带来额外压力。
相似文献
1
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.2020 年 4 月至 7 月，印度新冠肺炎重症患者中出现耐多药念珠菌血症感染。
Emerg Infect Dis. 2020 Nov;26(11):2694-2696. doi: 10.3201/eid2611.203504. Epub 2020 Aug 27.
2
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic.新冠疫情期间多重耐药耳念珠菌这一潜在祸害。
J Glob Antimicrob Resist. 2020 Sep;22:175-176. doi: 10.1016/j.jgar.2020.06.003. Epub 2020 Jun 12.
3
The first case of clade I Candida auris candidemia in a patient with COVID-19 in Japan.日本首例 COVID-19 患者感染谱系 I 耳念珠菌血症。
J Infect Chemother. 2023 Jul;29(7):713-717. doi: 10.1016/j.jiac.2023.03.018. Epub 2023 Mar 29.
4
Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind.二十一世纪全球真菌性传染病的皮肤表现，可能使人类共同面临的 COVID-19 大流行更加复杂。
Dermatol Ther. 2020 Jul;33(4):e13481. doi: 10.1111/dth.13481. Epub 2020 May 27.
5
Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options.新冠肺炎阳性患者的真菌感染：缺乏最佳治疗方案
Curr Top Med Chem. 2020;20(22):1951-1957. doi: 10.2174/156802662022200917110102.
6
Bloodstream infections in critically ill patients with COVID-19.COVID-19 重症患者血流感染。
Eur J Clin Invest. 2020 Oct;50(10):e13319. doi: 10.1111/eci.13319. Epub 2020 Aug 11.
7
Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID-19) patients: A systematic review.新型冠状病毒肺炎（COVID-19）患者中耐多药耳念珠菌感染的流行情况、危险因素、治疗方法和结局：系统评价。
Mycoses. 2022 Jun;65(6):613-624. doi: 10.1111/myc.13447.
8
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
9
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
10
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.COVID-19 患者住院期间到出院时粪便真菌微生物组的改变。
Gastroenterology. 2020 Oct;159(4):1302-1310.e5. doi: 10.1053/j.gastro.2020.06.048. Epub 2020 Jun 26.
引用本文的文献
1
A Comprehensive Review of Epidemiology, Risk Factors, Clinical Manifestations, Antifungal Susceptibility, and Mortality of Candida auris in Saudi Arabia.沙特阿拉伯耳念珠菌的流行病学、危险因素、临床表现、抗真菌药敏性及死亡率的综合综述
Cureus. 2025 Aug 5;17(8):e89455. doi: 10.7759/cureus.89455. eCollection 2025 Aug.
2
Increasing antifungal resistance in Eastern India (2019-2023): A notable rise in amphotericin B resistance.印度东部地区抗真菌耐药性增加（2019 - 2023年）：两性霉素B耐药性显著上升。
Curr Med Mycol. 2024 Nov 15;10. doi: 10.22034/cmm.2024.345262.1555. eCollection 2024.
3
Emergence of multidrug-resistant and opportunistic fungal infections due to in intensive care units.重症监护病房中多重耐药和机会性真菌感染的出现。
Curr Med Mycol. 2024 Mar 1;10. doi: 10.22034/cmm.2024.345249.1558. eCollection 2024.
4
Managing Candida auris in dialysis units: challenges, strategies, and future directions.透析单位中耳念珠菌的管理：挑战、策略及未来方向。
Int Urol Nephrol. 2025 Jun 13. doi: 10.1007/s11255-025-04600-4.
5
Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris.靶向表观遗传调节因子以克服新兴人类真菌病原体耳念珠菌中的耐药性。
Nat Commun. 2025 May 20;16(1):4668. doi: 10.1038/s41467-025-59898-6.
6
Diagnostic Challenges in Fungal Coinfections Associated With Global COVID-19.与全球新冠疫情相关的真菌合并感染的诊断挑战
Scientifica (Cairo). 2025 May 7;2025:6840605. doi: 10.1155/sci5/6840605. eCollection 2025.
7
Impact of on Critically Ill Patients: A Three-Year Observational Study in a Greek Intensive Care Unit.对危重症患者的影响：希腊一家重症监护病房的三年观察性研究。 （注：原文中“Impact of ”后面缺少具体内容，根据常见情况推测可能是某个因素对危重症患者的影响，所以在翻译时补充了“对”字，以使译文完整通顺）
Pathogens. 2025 Mar 28;14(4):328. doi: 10.3390/pathogens14040328.
8
Characterization of COVID-19-Associated Candidemia Among Burn Patients.烧伤患者中与COVID-19相关的念珠菌血症的特征
J Clin Lab Anal. 2025 May;39(10):e70031. doi: 10.1002/jcla.70031. Epub 2025 Apr 8.
9
Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond.关键真菌合并感染：流行病学、发病机制及其他
mBio. 2025 May 14;16(5):e0056225. doi: 10.1128/mbio.00562-25. Epub 2025 Apr 2.
10
: A Continuing Threat.持续的威胁。
Microorganisms. 2025 Mar 13;13(3):652. doi: 10.3390/microorganisms13030652.
本文引用的文献
1
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.COVID-19 患者住院期间到出院时粪便真菌微生物组的改变。
Gastroenterology. 2020 Oct;159(4):1302-1310.e5. doi: 10.1053/j.gastro.2020.06.048. Epub 2020 Jun 26.
2
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic.新冠疫情期间多重耐药耳念珠菌这一潜在祸害。
J Glob Antimicrob Resist. 2020 Sep;22:175-176. doi: 10.1016/j.jgar.2020.06.003. Epub 2020 Jun 12.
3
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
4
Clinical Outcomes of Patients Treated for Candida auris Infections in a Multisite Health System, Illinois, USA.美国伊利诺伊州多地点卫生系统中治疗耳念珠菌感染患者的临床结局。
Emerg Infect Dis. 2020 May;26(5):876-880. doi: 10.3201/eid2605.191588.
5
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
6
Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China.新型冠状病毒肺炎患者的医院感染：来自中国武汉某单一中心918例病例的回顾性数据分析
Infect Control Hosp Epidemiol. 2020 Aug;41(8):982-983. doi: 10.1017/ice.2020.126. Epub 2020 Apr 13.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
9
Epidemiology, clinical characteristics, resistance, and treatment of infections by .……感染的流行病学、临床特征、耐药性及治疗情况
J Intensive Care. 2018 Oct 29;6:69. doi: 10.1186/s40560-018-0342-4. eCollection 2018.
10
Candida auris in Healthcare Facilities, New York, USA, 2013-2017.美国纽约，2013-2017 年医疗机构中的耳念珠菌。
Emerg Infect Dis. 2018 Oct;24(10):1816-1824. doi: 10.3201/eid2410.180649.
Zotero 插件